Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.110
-0.170 (-13.28%)
Nov 16, 2026, 4:00 PM EST - Market closed

Cabaletta Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
28.5129.5727.9419.2414.8413.82
Research & Development
165.12142.6797.255.4239.332.49
Operating Expenses
193.64172.24125.1474.6654.1446.31
Operating Income
-193.64-172.24-125.14-74.66-54.14-46.31
Interest Expense
-2.22-2-0.75---
Interest & Investment Income
6.156.0310.036.991.160.02
Other Non Operating Income (Expenses)
0.20.36----
EBT Excluding Unusual Items
-189.51-167.86-115.86-67.68-52.98-46.29
Pretax Income
-189.51-167.86-115.86-67.68-52.98-46.29
Net Income
-189.51-167.86-115.86-67.68-52.98-46.29
Net Income to Common
-189.51-167.86-115.86-67.68-52.98-46.29
Net Income Growth
------
Shares Outstanding (Basic)
1398050412926
Shares Outstanding (Diluted)
1398050412926
Shares Change
109.16%61.34%20.95%39.54%14.01%11.20%
EPS (Basic)
-1.37-2.10-2.34-1.65-1.81-1.80
EPS (Diluted)
-1.37-2.10-2.34-1.65-1.81-1.80
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-162.51-132.31-90.43-54.24-48.83-35.28
Free Cash Flow Per Share
-1.17-1.66-1.83-1.32-1.66-1.37
EBITDA
-192.23-170.6-123.43-73.23-52.96-45.58
D&A For EBITDA
1.41.651.711.431.180.73
EBIT
-193.64-172.24-125.14-74.66-54.14-46.31
SEC Filings: 10-K · 10-Q